What was the total stockholder's equity for Learningrx in 2022?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
| 2023 | 2022 | |
|---|---|---|
| Liabilities And Stockhol | lders' Equity | |
| Stockholder's Equity | ||
| Common stock, no par value; 1,000 shares | ||
| authorized, issued, and outstanding | 50,000 | 50,000 |
| Retained earnings | 773,206 | 766,026 |
| Total Stockholders' Equity | 823,206 | 816,026 |
| Total Liabilities and Stockholders' Equity | $ 1,193,149 | $ 1,263,576 |
Source: Item 23 — RECEIPT (FDD pages 54–209)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the total stockholder's equity for the company in 2022 was $816,026. This figure represents the net worth of Learningrx attributable to its stockholders, calculated by subtracting total liabilities from total assets. It comprises common stock valued at $50,000 and retained earnings of $766,026.
For a prospective Learningrx franchisee, this number provides insight into the financial stability and capitalization of the franchisor. A higher stockholder's equity generally indicates a stronger financial position, suggesting that Learningrx has sufficient assets to cover its liabilities and invest in future growth. This can be reassuring for franchisees who are considering investing in the brand.
It's important to note that while stockholder's equity is a valuable metric, it should be considered alongside other financial indicators, such as revenue, profitability, and cash flow, to gain a comprehensive understanding of Learningrx's financial health. Additionally, franchisees should compare Learningrx's stockholder's equity to that of other franchise systems in the same industry to benchmark its financial performance.
Furthermore, the FDD also shows the total stockholder's equity for 2023, which was $823,206. This indicates a slight increase in stockholder's equity from 2022 to 2023. Reviewing these figures over multiple years can reveal trends in the company's financial performance and stability.